FDA Inspection 1041354 — Ann-Lii Cheng
The FDA completed an inspection of Ann-Lii Cheng on Jan 12, 2018 in Taipei City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 12, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Taipei City (Taiwan)
Additional details
Clinical Investigator (CI)